Towards Improved Peptidic α‐Ketoamide Inhibitors of the Plasmodial Subtilisin‐Like SUB1: Exploration of N‐Terminal Extensions and Cyclic Constraints

Archive ouverte

Puszko, Anna | Batista, Fernando | Ejjoummany, Abdelaziz | Bouillon, Anthony | Maurel, Manon | Adler, Pauline | Legru, Alice | Martinez, Mariano | Ortega Varga, Laura | Hadjadj, Margot | Alzari, Pedro Maria | Blondel, Arnaud | Haouz, Ahmed | Barale, Jean-Christophe | Hernandez, Jean-François

Edité par CCSD ; Wiley-VCH Verlag -

International audience. After more than 15 years of decline, the Malaria epidemy has increased again since 2017, reinforcing the need to identify drug candidates active on new targets involved in at least two biological stages of the Plasmodium life cycle. The SUB1 protease, which is essential for parasite egress in both hepatic and blood stages, would meet these criteria. We previously reported the structure‐activity relationship analysis of α‐ketoamide‐containing inhibitors encompassing positions P4‐P2’. Despite compounds with high inhibitory potencies were identified, their antiparasitic activity remained limited, probably due to insufficient cell permeability. Here, we present our efforts to improve it through the N‐terminal introduction of basic or hydrophobic moieties and/or cyclization. Compared to our previous reference compounds 1/2 (Ac‐Ile/Cpg‐Thr‐Ala‐AlaCO‐Asp‐Glu(Oall)‐NH2), we identified analogues with improved Pf‐/PvSUB1 inhibition (IC50 values in the 10‐20 nM range) and parasite growth inhibition (up to 98% at 100 μM). The increase in potency was mainly observed when increasing the overall hydrophobicity of the compounds. Conjugation to the cell penetrating peptide octa‐arginine was also favorable. Finally, the crystal structure of PvSUB1 in complex with compound 15 has been determined at 1.6 Å resolution. Compared to compound 1, this structure extended to the P5 residue and revealed two additional hydrogen bonds.

Suggestions

Du même auteur

Insights from structure-activity relationships and the binding mode of peptidic α-ketoamide inhibitors of the malaria drug target subtilisin-like SUB1

Archive ouverte | Legru, Alice | CCSD

International audience. Plasmodium multi-resistance, including against artemisinin, seriously threatens malaria treatment and control. Hence, new drugs are urgently needed, ideally targeting different parasitic stag...

Synthesis and evaluation of Plasmodium SUB1 inhibitors, a potential target for Malaria treatment

Archive ouverte | Legru, Alice | CCSD

International audience. Malaria is the most important human parasitic disease, with more than 200 million cases every year and 450 thousands deaths, 90% of them in Africa (WHO, 2018). Plasmodium multi-resistance, in...

3D structures of the Plasmodium vivax subtilisin-like drug target SUB1 reveal conformational changes to accommodate a substrate-derived α-ketoamide inhibitor

Archive ouverte | Martinez, Mariano | CCSD

International audience. The constant selection and propagation of multi-resistant Plasmodium sp. parasites require the identification of new antimalarial candidates involved in as-yet untargeted metabolic pathways. ...

Chargement des enrichissements...